UAE
Bahrain
Jordan
Kuwait
Oman
Qatar
Saudi ArabiaHealth News
Marijuana Use Doubles Risk Of Stroke
Date: Feb-06-2013The most popular illegal drug, marijuana, has been found to double the risk of stroke among young adults, according to findings revealed at The American Stroke Association's International Stroke Conference 2013. The study, carried out in New Zealand, identified that marijuana smokers were more than twice as likely than healthy adults to have suffered an ischemic stroke and transient ischemic attack (TIA). Lead investigator of the study, P. Alan Barber, Ph.D., M.D., said: "This is the first case-controlled study to show a possible link to the increased risk of stroke from cannabis...
Nerve Fibers Continue To Survive In Multiple Sclerosis
Date: Feb-06-2013Scientists found that the axons in rats with multiple sclerosis (MS) can survive for a long time, even after the myelin sheath that insulates the nerves is gone. This challenges the accepted view on MS. Multiple sclerosis (MS) is a brain disease caused by nerves losing their electrical insulation and the degeneration of nerve fibers called axons. It was previously thought by most scientists that once axons lose their insulation they are unable to function...
Developing Preclinical Models To Mimic Exacerbations Of COPD And Asthma, 15-16 April 2013, London
Date: Feb-06-2013SMi's highly respected Asthma & COPD conference returns to London on the 15th & 16th April 2013 to bring you an esteemed panel of speakers from industry and academia with a packed agenda bursting with detail and insights from within the platforms of both Asthma & COPD. The 9th Annual Asthma & COPD event comes at a perfect time to discuss latest developments and challenges alongside strategies to improve patient outcomes...
16th Annual Generics And Patent Strategies London, 13-14 May 2013
Date: Feb-06-2013SMi is pleased to announce the 16th annual Generics and Patent Strategies conference taking place in London from 13-14 May 2013. The conference will see world-renowned experts present the hottest topics and key challenges faced within the Generics industry today in combination with panel discussions, that will provide the latest updates on increasing profitability in a highly competitive market, how to overcome some of the IP issues faced when challenging patents and takes a detailed look at the pricing pressures surrounding an already saturated marketplace...
Pfizer And Boehringer Ingelheim Pharmaceuticals To Feature In Line Up At Extractables And Leachables USA Conference 7-9 May 2013, Providence, RI
Date: Feb-06-2013Extractables and Leachables USA 2013 (E&L USA) have released their full agenda for 2013. The 3 day event will feature a pre-conference workshop, poster sessions and a 2 day speaker program covering case studies on materials composition and quality, toxicological perspectives on E&Ls and challenges in E&L studies. Smithers Rapra's annual Extractables and Leachables conferences attract a wide range of delegates...
2nd Annual ADC Summit 2013 London, 20-21 May
Date: Feb-06-2013SMi's ADC Summit 2013 has returned and will be held on the 20th to 21st May. This year's event will present a unique insight into latest technological and scientific developments and will be the perfect platform for debate and problem-solving discussion as well as an in-depth view into novel innovations, developments and utilities of antibody-drug conjugates that will see world-renowned expert speakers from Immunogen, UCB, Bayer, MedImmune, Spirogen and Genentec. SMi is pleased to confirm John Hartley, Head of Biology of Spirogen as one of the speakers of the upcoming event...
Generic Version Of Cancer Drug Doxil Approved By FDA
Date: Feb-06-2013The U.S. Food and Drug Administration has just approved a generic version of the cancer drug Doxil (doxorubicin hydrochloride liposome injection). There is currently a serious shortage of the drug Doxil, and the decision by the FDA to allow a generic version on the market will help the thousands of people in need of the drug to survive. The generic version of Doxil is developed by Sun Pharma Global FZE, a subsidiary of India's Sun Pharmaceutical Industries Ltd. Doxil, which is made by Johnson and Johnson. The medication is used to treat Ovarian cancer as well as multiple myeloma...
Pitt Cancer Institute Researchers Reveal Mechanism To Halt Cancer Cell Growth, Discover Potential Cancer Therapy
Date: Feb-06-2013University of Pittsburgh Cancer Institute (UPCI) researchers have uncovered a technique to halt the growth of cancer cells, a discovery that led them to a potential new anti-cancer therapy. When deprived of a key protein, some cancer cells are unable to properly divide, a finding described in the cover story of the February issue of the Journal of Cell Science. This research is supported in part by a grant from the National Institutes of Health...
Overdose Education And Nasal Naloxone Rescue Kits For Bystanders Associated With Decreased Opioid Overdose Death
Date: Feb-06-2013In a study of communities in Massachusetts with high numbers of opioid overdose deaths, the implementation of overdose education and naloxone distribution (OEND) was associated with a significant reduction in opioid overdose death rates...
Some Cancer Mutations Slow Tumor Growth
Date: Feb-06-2013Surprising result suggests that enhancing these mutations' impact could offer a new way to treat cancer. A typical cancer cell has thousands of mutations scattered throughout its genome and hundreds of mutated genes. However, only a handful of those genes, known as drivers, are responsible for cancerous traits such as uncontrolled growth. Cancer biologists have largely ignored the other mutations, believing they had little or no impact on cancer progression...
Stay Connected
